Abstract
Metabolic syndrome (MetS) is characterized by abnormal adipose tissue distribution, insulin resistance, atherogenic dyslipidemia, hypertension, chronic inflammation and procoagulant milieu. Metabolic syndrome comprises independent cardiovascular risk factors and simultaneously represents a risk factor for cardiovascular events and diabetes in the general population. In the absence of specific diagnostic criteria in pregnancy, the present study aims to analyze the role of Metabolic Syndrome Severity Score in pregnant women. The value of the MetS severity score in pregnant women in their first trimester of pregnancy can be used to predict the development of maternal and fetal complications. The MetS severity score showed an increased predictive power for the development of gestational diabetes, preeclampsia, macrosomia and for the need for child admission in neonatal intensive care.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
